Recordati sizes up €10.9bn CVC Capital acquisition offer

0
97

Italian pharmaceutical company, Recordati, has confirmed that it’s weighing an acquisition offer from private equity manager, CVC, which is looking to solidify its controlling stake in the company.

If Recordati greenlights this deal, CVC would pay €52 ($60) per share for the remaining 48.2% of the former company’s shares available on the Italian Stock Exchange – potentially setting CVC back by €10.9bn ($12.6bn).

While Recordati noted it has “not yet reviewed the indication of interest within its corporate bodies” for this deal, the company already has strong ties with CVC, as the firm previously acquired a controlling stake in Recordati by buying 51.8% of its stock for €3.03bn in 2018.

Recordati, which celebrates its 100th birthday this year, is a global pharmaceutical group focused on primary and secondary care, as well as rare diseases within the areas…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here